These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 4961207)

  • 1. Changes in the weight and composition of the liver in the rat, dog and monkey treated with ethyl chlorophenoxyisobutyrate.
    Platt DS; Thorp JM
    Biochem Pharmacol; 1966 Jul; 15(7):915-25. PubMed ID: 4961207
    [No Abstract]   [Full Text] [Related]  

  • 2. Changes in the liver concentrations of the nicotinamide adenine dinucleotide coenzymes and in the activities of oxidoreductase enzymes following treatment of the rat with ethyl chlorophenoxyisobutyrate (Atromid-S).
    Platt DS; Cockrill BL
    Biochem Pharmacol; 1966 Jul; 15(7):927-35. PubMed ID: 4381792
    [No Abstract]   [Full Text] [Related]  

  • 3. The hypocholesterolemic effect of phenyramidol.
    Schrogie JJ
    Clin Pharmacol Ther; 1966; 7(6):723-6. PubMed ID: 5918008
    [No Abstract]   [Full Text] [Related]  

  • 4. Increase of hepatic mitochondria on administration of ethyl alpha-p-chlorophenoxyisobutyrate to the rat.
    Kurup CK; Aithal HN; Ramasarma T
    Biochem J; 1970 Mar; 116(5):773-9. PubMed ID: 5441366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of N-gamma-phenylpropyl-N-benzyloxy acetamide (W-1372) and of clofibrate on the lipids of normal and hypercholesteremic rats.
    Berger FM; Douglas JF; Lu GG; Ludwig BJ
    Proc Soc Exp Biol Med; 1969 Oct; 132(1):293-7. PubMed ID: 5344849
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of ethylchlorophenoxyisobutyrate on weight, plasma volume, total body-water, and free fatty acids.
    Macmillan DC; Oliver MF; Simpson JD; Tothill P
    Lancet; 1965 Nov; 2(7419):924-6. PubMed ID: 4165275
    [No Abstract]   [Full Text] [Related]  

  • 7. Morphological and biochemical changes in rat liver during the early stages of ethyl chlorophenoxyisobutyrate administration.
    Kaneko A; Sakamoto S; Morita M; Onoe T
    Tohoku J Exp Med; 1969 Sep; 99(1):81-101. PubMed ID: 4390771
    [No Abstract]   [Full Text] [Related]  

  • 8. Decrease of ethanol-induced fatty liver by ethyl alpha-p-chlorophenoxyisobutyrate.
    Spritz N; Lieber CS
    Proc Soc Exp Biol Med; 1966 Jan; 121(1):147-9. PubMed ID: 5902917
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of clofibrate on Tetrahymena.
    Blum JJ; Wexler JP
    Mol Pharmacol; 1968 Mar; 4(2):155-61. PubMed ID: 5645611
    [No Abstract]   [Full Text] [Related]  

  • 10. The effect of hypocholesteremic agents on myelinogenesis.
    Fumagalli R; Smith ME; Urna G; Paoletti R
    J Neurochem; 1969 Sep; 16(9):1329-39. PubMed ID: 5808099
    [No Abstract]   [Full Text] [Related]  

  • 11. Degradation kinetics of liver catalase in rats treated with ethyl-alpha-p-chlorophenoxyisobutyrate.
    Chiga M; Reddy J; Svoboda D
    Lab Invest; 1971 Jul; 25(1):49-52. PubMed ID: 5555696
    [No Abstract]   [Full Text] [Related]  

  • 12. Nature of the hepatomegalic effect produced by ethyl-chlorophenoxy-isobutyrate in the rat.
    Hess R; Stäubli W; Riess W
    Nature; 1965 Nov; 208(5013):856-8. PubMed ID: 5870099
    [No Abstract]   [Full Text] [Related]  

  • 13. The effect of ethyl alpha-p. chlorophenoxyisobutyrate on ethanol-induced hepatic steatosis in the rat.
    Brown DF
    Metabolism; 1966 Oct; 15(10):868-73. PubMed ID: 5923523
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of clofibrate (ethyl-chlorophenoxyisobutyrate) feeding on glycolytic and lipogenic enzymes and hepatic glycogen synthesis in the rat.
    Zakim D; Paradini RS; Herman RH
    Biochem Pharmacol; 1970 Jan; 19(1):305-10. PubMed ID: 5507646
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effect of atromid S on certain fractions of collagen from the aortic wall of rats being on atherogenic diet].
    Hanzlik J; Lopatyński J; Tyburczyk W
    Pol Tyg Lek; 1967 Jan; 22(2):48-50. PubMed ID: 6040630
    [No Abstract]   [Full Text] [Related]  

  • 16. Influence of chlorophenoxyisobutyrate (CPIB) on thyroid parameters.
    Hansen JM
    Acta Endocrinol (Copenh); 1969 Feb; 60(2):294-302. PubMed ID: 4979609
    [No Abstract]   [Full Text] [Related]  

  • 17. The effect of clofibrate on thrombocyte adhesivity and some coagulation parameters.
    Dybkaer R; Geill T
    Gerontol Clin (Basel); 1967; 9(3):157-66. PubMed ID: 6055296
    [No Abstract]   [Full Text] [Related]  

  • 18. The effect of chlorophenoxyisobutyric acid on the release of free fatty acids from isolated adipose tissue in vitro.
    Barrett AM
    Br J Pharmacol Chemother; 1966 Feb; 26(2):363-71. PubMed ID: 5912683
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of rubratoxin B on liver composition and metabolism in the mouse.
    Hayes AW; Wilson BJ
    Toxicol Appl Pharmacol; 1970 Sep; 17(2):481-93. PubMed ID: 5471563
    [No Abstract]   [Full Text] [Related]  

  • 20. The mechanisms underlying the hypolipidaemic effects of atromid S, nicotinic acid and benzalecene. I. The metabolism of free fatty acid-albumin complex by the isolated perfused liver.
    Mishkel MA; Webb WF
    Biochem Pharmacol; 1967 May; 16(5):897-905. PubMed ID: 6036737
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.